PO-55: Effectiveness and safety of enoxaparin in the extended treatment of venous thromboembolism in active cancer patients with renal impairment: results from the RIETECAT-RI cohort study. Issue 213 (May 2022) - López-Núñez, J.J.; Trujillo-Santos, J.; Bertoletti, L.; Lobo, J.L.; Visonà, A.; Otero-Candelera, R.; Ruiz-Sada, P.; De Ancos, C.; Mahé, I.; Monreal, M.